Indeed, the researchers found that both IL-12 and IL-23 were abundantly expressed (compared to healthy control subjects) by activated macrophages infiltrating the papillary and reticular dermis in HS lesions [144]. The gene discussed is IL37; the disease is histiocytic sarcoma.